Caricamento...
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
BACKGROUND: Boceprevir and telaprevir have recently showed dramatically better treatment outcomes than conventional PEGylated interferon plus ribavirin for the treatment of hepatitis C virus genotype 1, but the average cost per patient is unknown. METHODS: In the UK context, we performed a budget im...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3503472/ https://ncbi.nlm.nih.gov/pubmed/23180971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S37205 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|